Healthdirect Australia is not responsible for the content and advertising on the external website you are now entering.
Brand name: Paxlovid TM
Listen to the Pronunciation:
Active ingredients: nirmatrelvir, ritonavir
What it is used for
PAXLOVID has provisional approval for the treatment of coronavirus disease 2019 (COVID-19) in adults 18 years of age and older, who do not require initiation of supplemental oxygen due to COVID-19 and are at increased risk of progression to hospitalisation or death (see Section 5.1 Pharmacodynamic properties, Clinical trials).,The decision has been made on the basis of short term efficacy and safety data. Continued approval of this indication depends on the efficacy and safety data from ongoing clinical trials and post-market assessment.
How to take it
This medicine is a pack that contains more than one part.
Part 1: Tablet, film coated
Oval, pink film-coated debossing of pfe on one side and 3cl on the other.,white to off-white oval tablets marked with abbott logo and nk.
The way to take this medicine is: Oral. This medicine is taken by mouth.
Part 2: Tablet, film coated
white film-coated oval tablets debossed with the corporate Abbott logo and the Abbott-Code NK
The way to take this medicine is: Oral. This medicine is taken by mouth.
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
Always read the label. If symptoms persist see your healthcare professional.
Storage instructions
- Store below 25 degrees Celsius
- Shelf lifetime is 24 Months.
Do I need a prescription?
This medicine is available from a pharmacist and requires a prescription. It is
Is this medicine subsidised?
This medicine was verified as being available on the PBS (Pharmaceutical Benefits Scheme) on March 1, 2023. To learn more about this subsidy, visit the Pharmaceutical Benefits Scheme (PBS) website.
Pregnant or planning a pregnancy?
For the active ingredient nirmatrelvir
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
For the active ingredient ritonavir
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Consumer Medicines Information (CMI)
For side effects, taking other medicines and more
Reporting side effects
This medicine is under additional monitoring as it is new or being used in a different way. You can help identify new safety information by reporting any side effects you may get.
- You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems.
- For more information on the Black Triangle Scheme and how to report side effects, see www.tga.gov.au/black-triangle-scheme
Need more information?
These trusted information partners have more on this topic.
Top results
Factsheet: Paxlovid for people with mild COVID-19 - NPS MedicineWise
You have been given a medicine for COVID-19. It is called Paxlovid. This medicine can stop you from getting very sick or needing to go to hospital. This factsheet explains the medicine and how to use it.
Read more on NPS MedicineWise website
TGA provisionally approves two oral COVID-19 treatments, molnupiravir (LAGEVRIO) and nirmatrelvir + ritonavir (PAXLOVID) | Therapeutic Goods Administration (TGA)
The TGA has granted provisional approval to two oral COVID-19 treatments.
Read more on TGA – Therapeutic Goods Administration website
COVID-19 treatments | Therapeutic Goods Administration (TGA)
Find the latest regulatory and safety information on COVID-19 treatments in Australia.
Read more on TGA – Therapeutic Goods Administration website
What you need to know about COVID-19 - Immunisation Coalition
What you need to know about COVID-19 so you can protect yourself, your friends, family and the rest of the community.
Read more on Immunisation Coalition website
Top results
